Suchergebnisse
Suchergebnisse:
The Michael J. Fox Foundation funds promising research with a goal to significantly improve the lives of people with Parkinson's. We welcome applications from academia and industry for support to define, measure and treat Parkinson's.
The Michael J. Fox Foundation launched PPMI in 2010. Since then, the study has changed how research is done and what scientists know about the brain. PPMI follows people — with and without Parkinson's — over time to learn more about how disease starts and changes. That information can help doctors and scientists better diagnose, treat and ...
Michael J. Fox, iconic actor, author and advocate whose Hollywood career has been marked by worldwide acclaim, honor and awards, launched the Foundation in 2000 after publicly disclosing his 1991 diagnosis, at age 29, with Parkinson’s disease.
4. Juni 2024 · With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever." Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
Mit der Internet-Plattform Fox Trial Finder bietet die Stiftung Parkinson-Patienten und ihre Angehörigen die kostenlosen Möglichkeit, sich über aktuelle Parkinson-Studien in Deutschland zu informieren. Als weltweit größter privater Geldgeber für die Parkinson-Forschung hat die Michael J. Fox Foundation for Parkinson’s Research (MJFF ...
The Michael J. Fox Foundation for Parkinson’s Research is recognized as a tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. To claim a donation as a deduction on your U.S. taxes, please keep your email donation receipt as your official record. We'll send it to you upon successful completion of your donation.
GP2 is a resource of the Aligning Science Across Parkinson's (ASAP) Initiative. It is an ambitious five-year program to genotype >150,000 volunteers around the world to further understand the genetic architecture of Parkinson’s disease (PD). There is still much to learn about genetic risk factors, and the path to further understanding requires working collaboratively and openly sharing data ...
